Oxford Genetics' unique high-throughput platform has been developed using Promega chemistry for antibody engineering in synthetic biology
19.12.2018
Oxford Genetics is a leading synthetic biology company focused on developing novel technologies to overcome the challenges associated with the discovery, development and production of biologics, gene therapies, cell therapies and vaccines. A unique high-throughput platform has been designed at Oxford Genetics for antibody engineering. Read here to find out how, Barry Kiely, our Field Support Scientist (FSS) in the UK has worked closely with Oxford Genetics, implementing the Promega chemistry on both the Hamilton star and HSM platforms, for plasmid and antibody purification.
The FSS are a dedicated team of liquid-handling specialists who work with and provide continuing support to customers in the implementation of high-throughput extraction and quantitation chemistries on complex liquid handling systems. For more information and to request a consult please visit https://www.promega.com/products/dna-purification-quantitation/high-throughput-nucleic-acid-purification/maxwell-ht-nucleic-acid-purification/